Here's Why NantKwest Rocketed Higher Today
Shares of NantKwest (NASDAQ: NK) are up 40% at 12:40 p.m. EDT after the company's CEO Patrick Soon-Shiong made an appearance on Fox Business' Maria Bartiromo's Wall Street to talk about NantKwest's COVID-19 vaccine.
While other companies such as Moderna (NASDAQ: MRNA) and Inovio (NASDAQ: INO) are developing vaccines to create antibodies to the spike protein on the outside of the virus, which should block the virus from entering the patient's cell, NantKwest has developed a vaccine expressing both the spike protein and the nucleocapsid protein on the inside of the virus.
Soon-Shiong hypothesizes that the nucleocapsid protein will be required to create memory T-cells that provide long-term immunity because patients who have survived other coronavirus outbreaks only had long-term memory T-cells that target the nucleocapsid protein.
Source Fool.com
